Fierce Pharma6h
Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
pharmaphorum1y
Pfizer, BioNTech submit to FDA for Covid vaccine in under 5s
The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...
Health on MSN3mon
Should Kids Get the COVID-19 Vaccine?
Children shouldn't receive the Moderna or Pfizer-BioNTech vaccines if they've had a severe allergic reaction to the ...
The Scientist3y
Moderna vs. Pfizer: Is There a “Best” mRNA Vaccine?
In multiple independent studies, significantly lower antibody levels and more vaccine breakthrough infections have been detected in the Pfizer/BioNTech-vaccinated population. These could be ...
Rappler29d
FACT CHECK: Post on alleged Pfizer COVID-19 vaccine side effects is false
The post claims that Pfizer just released a list of side effects of its COVID-19 vaccine. It then proceeds to enumerate over 40 alleged side effects, including heart failure, liver damage ...
pharmaphorum6d
Moderna sues Pfizer/BioNTech over COVID-19 vaccine tech
It's not the first time Pfizer and BioNTech have been accused of patent infringement with Comirnaty, as another mRNA COVID-19 vaccine developer – CureVac – filed a suit in Germany last month ...
The Motley Fool2y
Investing in Vaccine Stocks
In addition, Pfizer pays an attractive dividend, making the stock a favorite of income-seeking investors. This COVID-19 vaccine remains BioNTech's primary revenue source for now. However ...